A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers.
暂无分享，去创建一个
S. Kochhar | J. Excler | P. Fast | P. Hayes | J. Cox | J. Gilmour | D. Panicali | Angela Lombardo | E. Sayeed | G. Stevens | P. Narayanan | J. Ackland | J. Mahalingam | S. Solomon | B. Barin | T. Tarragona-Fiol | V. Ramanathan | K. Loughran | C. Verlinde | Makesh Kumar | Sekhar Chakrabarty | Danii Vooijs | Michelle Seth Smith | Pattabiraman Sathyamoorthy